At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- ELIOS (procedure), Competitor Device (procedure)
- How long the study runs
- Study runs about 60 months (dates as stated)
- About the drug or intervention
- ELIOS — procedure: Following cataract surgery, surgeon will proceed to ELIOS treatment. · Competitor Device — procedure: Following cataract surgery, surgeon will proceed to Competitor treatment.
- Patient visit burden
- Not specified by the sponsor
In plain English
This study looks at how well and how safely the ELIOS treatment works for people with open-angle glaucoma who are also having cataract surgery. Glaucoma is a condition where pressure in the eye can damage the optic nerve. It is run by Elios Vision, Inc.
Who can take part
- Men or women aged 40 or over
- Diagnosed with mild to moderate primary open-angle glaucoma, pseudoexfoliation glaucoma or pigmentary glaucoma
- Have a cataract that affects vision and can be treated with standard cataract surgery (phacoemulsification)
Who may not be able to
- Any type of angle closure glaucoma
- Other glaucoma caused by injury, abnormal blood vessels, inflammation, the lens, steroid medicines, or blood vessel problems
- Glaucoma present from birth or childhood
- Previous glaucoma surgery, other eye surgery, or any eye laser treatment — except selective laser trabeculoplasty (SLT) done at least 6 months before the screening visit
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team about how many visits there are and how long the study lasts.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Testing a treatment
- Ages
- 40 Years and over
- Who
- All
- Number of participants
- 194
- Started
- 2023-12-05
- Last checked
- 2026-06
Plain English Summary
What is this study?
- • Testing a new treatment for open angle glaucoma
- • NA - 194 participants
- • The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively
Who can take part?
- • Ages 40 Years and over
- • Diagnosed with open angle glaucoma
Where?
- • East Grinstead - ELIOS Clinical Site
- • Edinburgh - ELIOS Clinical Site
- • Guildford - ELIOS Clinical Site
- • London - ELIOS clinical site
- • +1 more UK sites
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 40 Years and over
- Who can join: All genders
What the study is looking for
- ✓Male or female subjects.
- ✓40 years old or older.
- ✓Diagnosis of mild to moderate primary open-angle glaucoma, pseudoexfoliation glaucoma or pigmentary glaucoma:
- ✓Visually significant cataract eligible for phacoemulsification.
Who cannot take part
- ✗All forms of angle closure glaucoma
- ✗Congenital or developmental glaucoma
See the full criteria
Where Is This Study? (5 UK sites)
ELIOS Clinical Site
East Grinstead, United Kingdom
ELIOS Clinical Site
Edinburgh, United Kingdom
ELIOS Clinical Site
Guildford, United Kingdom
ELIOS clinical site
London, United Kingdom
ELIOS Clinical Site
Manchester, United Kingdom
How to Get in Touch
Cameron Hudson
Sponsor contactCONTACT